Castle Rock Wealth Management LLC lifted its position in shares of Stryker Co. (NYSE:SYK) by 50.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,160 shares of the medical technology company’s stock after purchasing an additional 1,065 shares during the period. Castle Rock Wealth Management LLC’s holdings in Stryker were worth $534,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Quest Investment Management LLC purchased a new stake in Stryker during the second quarter worth about $12,762,000. Palisade Asset Management LLC increased its stake in shares of Stryker by 1.1% in the second quarter. Palisade Asset Management LLC now owns 37,904 shares of the medical technology company’s stock worth $6,400,000 after purchasing an additional 420 shares in the last quarter. Nissay Asset Management Corp Japan ADV increased its stake in shares of Stryker by 1.4% in the second quarter. Nissay Asset Management Corp Japan ADV now owns 40,024 shares of the medical technology company’s stock worth $6,758,000 after purchasing an additional 544 shares in the last quarter. Wade G W & Inc. increased its stake in shares of Stryker by 21.4% in the first quarter. Wade G W & Inc. now owns 4,096 shares of the medical technology company’s stock worth $659,000 after purchasing an additional 722 shares in the last quarter. Finally, Toronto Dominion Bank increased its stake in shares of Stryker by 19.2% in the second quarter. Toronto Dominion Bank now owns 208,179 shares of the medical technology company’s stock worth $35,146,000 after purchasing an additional 33,499 shares in the last quarter. 75.08% of the stock is currently owned by institutional investors.

Several equities analysts have recently weighed in on SYK shares. Zacks Investment Research downgraded shares of Stryker from a “buy” rating to a “sell” rating in a research note on Wednesday, July 18th. BTIG Research started coverage on shares of Stryker in a research note on Thursday, August 16th. They issued a “buy” rating and a $187.00 target price for the company. Cantor Fitzgerald reiterated a “hold” rating and issued a $170.00 target price on shares of Stryker in a research note on Wednesday, June 13th. ValuEngine downgraded shares of Stryker from a “buy” rating to a “hold” rating in a research note on Tuesday, June 12th. Finally, Sanford C. Bernstein started coverage on shares of Stryker in a research note on Wednesday, June 27th. They issued a “market perform” rating and a $177.00 target price for the company. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $177.25.

Shares of NYSE:SYK opened at $168.60 on Wednesday. The company has a market cap of $63.37 billion, a P/E ratio of 25.98, a PEG ratio of 2.38 and a beta of 0.59. Stryker Co. has a 12 month low of $138.94 and a 12 month high of $179.84. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.83 and a quick ratio of 1.15.

Stryker (NYSE:SYK) last issued its quarterly earnings data on Tuesday, July 24th. The medical technology company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.73 by $0.03. The company had revenue of $3.32 billion during the quarter, compared to analysts’ expectations of $3.31 billion. Stryker had a net margin of 8.28% and a return on equity of 26.93%. Stryker’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.53 earnings per share. equities research analysts anticipate that Stryker Co. will post 7.25 earnings per share for the current year.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

See Also: Book Value Per Share – BVPS

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.